Neuralink implanted brain chip in first human subject
On Jan. 29, 2024, Neuralink announced that the first human patient had received an implant from brain-chip and…
On Jan. 29, 2024, Neuralink announced that the first human patient had received an implant from brain-chip and…
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
On Jan. 12, 2024, the World Health Organization (WHO) announced it had certified Cabo Verde as a malaria-free…
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of…
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced study results that showed…
On Dec. 20, 2023, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratory (NVSL) announced it…
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Dec. 15, 2023, In a pivotal move towards addressing one of the worldメs most underrecognized health challenges,…
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Dec. 7, 2023, the U.S. Food and Drug Administration reported that of the more than 116 medically…
On Dec. 6, 2023, the federal government announced it had expanded the Home Test to Treat program, an…
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaᆴ (iptacopan)…
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
On Nov. 30, 2023, the U.S. Department of Department of Agricultureメs (USDA) Animal and Plant Health Inspection Service…
On Nov. 30, 2023, researchers at Tufts University announced they had created tiny biological robots that they call…
On Nov. 30, 2023, researchers at Hokkaido University, in collaboration with colleagues at Woods Hole Oceanographic Institution announced…
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
On Nov. 27, 2023, the CDCメs Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
On Nov. 23, 2023, Vertex announced that the European Medicines Agency (EMA) had validated a Type II variation…
On Nov. 21, 2023, the World Health Organization (WHO) reported that the BA.2.86 variant had been reported in…
On Nov. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced the National Strategic Germplasm and Cultivar Collection…